Product NDC: | 63323-542 |
Proprietary Name: | Heparin Sodium |
Non Proprietary Name: | HEPARIN SODIUM |
Active Ingredient(s): | 10000 [USP'U]/mL & nbsp; HEPARIN SODIUM |
Administration Route(s): | INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-542 |
Labeler Name: | APP Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA017029 |
Marketing Category: | NDA |
Start Marketing Date: | 20100618 |
Package NDC: | 63323-542-01 |
Package Description: | 25 VIAL in 1 TRAY (63323-542-01) > 1 mL in 1 VIAL |
NDC Code | 63323-542-01 |
Proprietary Name | Heparin Sodium |
Package Description | 25 VIAL in 1 TRAY (63323-542-01) > 1 mL in 1 VIAL |
Product NDC | 63323-542 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | HEPARIN SODIUM |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 20100618 |
Marketing Category Name | NDA |
Labeler Name | APP Pharmaceuticals, LLC |
Substance Name | HEPARIN SODIUM |
Strength Number | 10000 |
Strength Unit | [USP'U]/mL |
Pharmaceutical Classes | Anti-coagulant [EPC],Heparin [Chemical/Ingredient],Unfractionated Heparin [EPC] |